These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9597433)

  • 1. [Structures and actions of macrolide antibiotics].
    Sunazuka T
    Jpn J Antibiot; 1997 Mar; 50 Suppl A():20-7. PubMed ID: 9597433
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of biological activity of macrolide antibiotics--inhibitors of F0F1-ATPase].
    Bibikova MV; Grammatikova NE; Kabanov AE; Sazykin IuO; Katlinskiĭ AV
    Antibiot Khimioter; 2003; 48(12):33-9. PubMed ID: 15176103
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
    Kannan K; Mankin AS
    Ann N Y Acad Sci; 2011 Dec; 1241():33-47. PubMed ID: 22191525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolides: present and future. An appraisal of in-vitro activity and pharmacokinetic behavior.
    Furneri PM; Nicoletti G
    J Chemother; 1991 Jan; 3 Suppl 1():24-7. PubMed ID: 12041776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Types and characteristics of macrolides].
    Płusa T
    Pol Merkur Lekarski; 2008 Nov; 25(149):403-7. PubMed ID: 19177775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-polyenic antifungal macrolide antibiotics].
    Shenin IuD
    Antibiot Khimioter; 1991 Oct; 36(10):50-4. PubMed ID: 1805700
    [No Abstract]   [Full Text] [Related]  

  • 7. A new insight into solid-state conformation of macrolide antibiotics.
    Miroshnyk I; Mirza S; Zorky PM; Heinämäki J; Yli-Kauhaluoma J; Yliruusi J
    Bioorg Med Chem; 2008 Jan; 16(1):232-9. PubMed ID: 17936632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship of a novel class of 15-membered macrolide antibiotics known as '11a-azalides'.
    Sugimoto T; Tanikawa T; Suzuki K; Yamasaki Y
    Bioorg Med Chem; 2012 Oct; 20(19):5787-801. PubMed ID: 22925450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disciformycins A and B: 12-membered macrolide glycoside antibiotics from the myxobacterium Pyxidicoccus fallax active against multiresistant staphylococci.
    Surup F; Viehrig K; Mohr KI; Herrmann J; Jansen R; Müller R
    Angew Chem Int Ed Engl; 2014 Dec; 53(49):13588-91. PubMed ID: 25294799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting the natural metabolic diversity of Streptomyces venezuelae to generate unusual reduced macrolides.
    Park JW; Oh HS; Jung WS; Park SR; Han AR; Ban YH; Kim EJ; Kang HY; Yoon YJ
    Chem Commun (Camb); 2008 Nov; (44):5782-4. PubMed ID: 19009080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide antibiotic interaction and resistance on the bacterial ribosome.
    Poehlsgaard J; Douthwaite S
    Curr Opin Investig Drugs; 2003 Feb; 4(2):140-8. PubMed ID: 12669373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexaene H-85, a hexaene macrolide complex.
    Karadzić IM; Gojgić GD; Vucetić JI
    J Antibiot (Tokyo); 1991 Dec; 44(12):1452-3. PubMed ID: 1778794
    [No Abstract]   [Full Text] [Related]  

  • 13. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
    Eraković Haber V; Bosnar M; Kragol G
    Future Med Chem; 2014 Apr; 6(6):657-74. PubMed ID: 24895894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stereochemistry and synthesis of polyene macrolide antibiotics].
    Shenin IuD
    Antibiot Khimioter; 1991 Feb; 36(2):48-51. PubMed ID: 2025120
    [No Abstract]   [Full Text] [Related]  

  • 15. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.
    Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN
    Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new series of macrolide derivatives with 4''-O-saccharide substituents.
    Xu P; Chen XZ; Liu L; Jin ZP; Lei PS
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5527-31. PubMed ID: 20716487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The general mode of translation inhibition by macrolide antibiotics.
    Kannan K; Kanabar P; Schryer D; Florin T; Oh E; Bahroos N; Tenson T; Weissman JS; Mankin AS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(45):15958-63. PubMed ID: 25349425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of 4''-O-acyl derivatives of 14- and 15-membered macrolides linked to omega-quinolone-carboxylic unit.
    Skugor MM; Stimac V; Palej I; Lugarić D; Paljetak HC; Filić D; Modrić M; Dilović I; Gembarovski D; Mutak S; Eraković Haber V; Holmes DJ; Ivezić-Schoenfeld Z; Alihodzić S
    Bioorg Med Chem; 2010 Sep; 18(17):6547-58. PubMed ID: 20621489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice.
    Terao H; Asano K; Kanai K; Kyo Y; Watanabe S; Hisamitsu T; Suzaki H
    Mediators Inflamm; 2003 Aug; 12(4):195-202. PubMed ID: 14514469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the interactions of macrolide antibiotics with membrane-mimetics by NMR spectroscopy.
    Kosol S; Schrank E; Krajačić MB; Wagner GE; Meyer NH; Göbl C; Rechberger GN; Zangger K; Novak P
    J Med Chem; 2012 Jun; 55(11):5632-6. PubMed ID: 22612227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.